Crossmark

Patient-reported outcomes version of the common terminology criteria for adverse events and quality-of-life linear analogue self-assessment in breast cancer patients receiving radiation therapy: single-institution prospective registry

Crossref DOI link: https://doi.org/10.1186/s41687-021-00408-9

Published Online: 2022-01-10

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thorpe, C. S.

DeWees, T. A.

Golafshar, M. A.

Bhangoo, R. S.

Vern-Gross, T. Z.

McGee, L. A.

Wong, W. W.

Halyard, M. Y.

Keole, S. R.

Vargas, C. E.
License Information

Text and Data Mining valid from 2022-01-10

Version of Record valid from 2022-01-10
More Information

Article History

Received: 10 August 2021

Accepted: 23 December 2021

First Online: 10 January 2022

Declarations

:

: This study was approved by Mayo Clinic Institutional Review Board, IRB ID 19-000891.

: Informed consent was obtained from each patient to be included on the institutional prospective registry.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below